HyperRAB human and Moxetumomab Pasudotox-tdfk
Determining the interaction of HyperRAB human and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: rabies immune globulin, human
Brand name: Bayrab, HyperRAB, Imogam Rabies-HT, Kedrab
Synonyms: HyperRAB (human), HyperRAB S/D
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- HyperRAB human-Moxetumomab pasudotox-tdfk Intravenous
- HyperRAB human-Moxifloxacin
- HyperRAB human-Moxifloxacin (Systemic)
- HyperRAB human-Moxifloxacin Hydrochloride
- HyperRAB human-Moxifloxacin Injection
- HyperRAB human-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-HyperRAB S/D
- Moxetumomab Pasudotox-tdfk-HyperRHO S/D
- Moxetumomab Pasudotox-tdfk-HyperRHO S/D Full Dose
- Moxetumomab Pasudotox-tdfk-HyperRHO S/D Mini Dose
- Moxetumomab Pasudotox-tdfk-HyperSal
- Moxetumomab Pasudotox-tdfk-Hyperstat